Stockscreener 앱 받기
55.00
0.87%
-0.48
전일 마감가:
$55.48
열려 있는:
$55.19
하루 거래량:
4.49M
Relative Volume:
0.85
시가총액:
$9.87B
수익:
$1.27B
순이익/손실:
$-245.03M
주가수익비율:
-39.09
EPS:
-1.4071
순현금흐름:
$-245.36M
1주 성능:
+5.53%
1개월 성능:
+16.95%
6개월 성능:
-38.79%
1년 성능:
+6.08%
1일 변동 폭
$53.62
$56.22
1주일 범위
$48.91
$56.22
52주 변동 폭
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
명칭
Tempus Ai Inc
전화
800-976-5448
주소
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, DOCS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
55.00 | 9.87B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
171.60 | 28.03B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
52.58 | 10.16B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
82.40 | 6.96B | 1.31B | 215.20M | 408.32M | 2.4627 |
DOCS
Doximity Inc
|
24.98 | 4.61B | 637.78M | 239.40M | 307.21M | 1.1909 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 개시 | Jefferies | Underperform |
| 2026-04-13 | 업그레이드 | TD Cowen | Hold → Buy |
| 2026-02-19 | 개시 | Mizuho | Outperform |
| 2026-02-17 | 개시 | Robert W. Baird | Outperform |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-21 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-10-20 | 개시 | Canaccord Genuity | Buy |
| 2025-09-02 | 개시 | H.C. Wainwright | Buy |
| 2025-04-21 | 개시 | BTIG Research | Buy |
| 2025-02-25 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-02-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-02-05 | 재개 | TD Cowen | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Outperform |
| 2024-12-09 | 개시 | Guggenheim | Buy |
| 2024-11-11 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-10-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-08-12 | 개시 | Piper Sandler | Neutral |
| 2024-07-09 | 개시 | BofA Securities | Buy |
| 2024-07-09 | 개시 | JP Morgan | Overweight |
| 2024-07-09 | 개시 | Longbow | Buy |
| 2024-07-09 | 개시 | Loop Capital | Buy |
| 2024-07-09 | 개시 | Morgan Stanley | Overweight |
| 2024-07-09 | 개시 | Needham | Buy |
| 2024-07-09 | 개시 | Stifel | Buy |
| 2024-07-09 | 개시 | TD Cowen | Buy |
| 2024-07-09 | 개시 | William Blair | Outperform |
모두보기
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Why Tempus AI (TEM) Is Up 5.5% After Major USC Precision-Medicine Data Partnership News - Yahoo Finance
Hussman Strategic Advisors Inc. Purchases 21,000 Shares of Tempus AI, Inc. $TEM - MarketBeat
Artificial Intelligence Stocks To Keep An Eye OnMay 2nd - MarketBeat
Tempus AI (TEM) Stock Gains Recognition on TIME’s 2026 Health Influencer List - MEXC
Best Artificial Intelligence Stocks Worth WatchingMay 1st - MarketBeat
Tempus AI’s Big May: Why Q1 Results and First Investor Day Put TEM Stock in Focus - TechStock²
Tempus AI (TEM) Stock Named to TIME’s Most Influential Health Companies of 2026 - CoinCentral
Tempus AI (TEM) Partners with Keck Medicine of USC to Integrate AI Across Healthcare Network - Insider Monkey
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 166,250 Shares of Stock - MarketBeat
Tempus AI Faces Class Action Cases for Collection of Genetic Information in Acquisition - The National Law Review
TEM Stock Price Prediction 2025-2026 | Tempus AI, Inc. Class A Common Stock Forecast | 24/7 Wall St. - 24/7 Wall St.
Tempus AI(TEM.US) 10% Shareholder Sells US$8.5 Million in Common Stock - Moomoo
Tempus AI (TEM) CEO’s entities sell 166,250 shares under Rule 10b5-1 plan - Stock Titan
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now? - Insider Monkey
5 Best Up and Coming Stocks with Highest Upside Potential - Insider Monkey
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now? - Yahoo Finance
Assessing Tempus AI (TEM) Valuation After A Recent Share Price Bounce - Yahoo Finance
Artificial Intelligence Stocks Worth WatchingApril 30th - MarketBeat
How The Tempus AI (TEM) Narrative Is Shifting Around Data, Partnerships And Growth Visibility - Yahoo Finance
Tempus AI Stock Surges on Fresh Recognition Buzz - TipRanks
Tempus AI’s TIME Honor And USC Deal Test Its Long Term Thesis - Yahoo Finance
Best Artificial Intelligence Stocks To ConsiderApril 29th - MarketBeat
Tempus to Host Inaugural Investor Day on May 29, 2026 - 01net
GC Wealth Management RIA LLC Invests $399.27 Million in Tempus AI, Inc. $TEM - MarketBeat
Bogart Wealth LLC Raises Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat
Tempus AI shares gain after expanded partnership with Gilead - MSN
Multiple Class A Common sales reported by holders (NASDAQ: TEM) - Stock Titan
Tempus AI (TEM) to Release Earnings on Tuesday - MarketBeat
Tempus AI (TEM) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026 - Business Wire
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI (TEM) Proxy filing Summary - Quartr
Tempus AI will acquire Paige for $81.25M - MSN
Tempus AI Stock Before Q1 Earnings Release: To Buy or Not to Buy? - Yahoo Finance
Tempus AI, Inc. $TEM Stake Cut by Renaissance Capital LLC - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: Uncovering the Potential 38.91% Upside with Cutting-Edge Healthcare Technology - DirectorsTalk Interviews
What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? - MSN
Guggenheim Maintains Tempus AI (TEM) Buy Recommendation - MSN
Artificial Intelligence Stocks To ConsiderApril 26th - MarketBeat
Tempus AI stock near 1-year low: Cathie Wood’s ARK buys more while offloading Nvidia, Meta, other tech plays - MSN
Can Tempus AI’s (TEM) USC Partnership Quietly Redefine Its Clinical Data Moat? - simplywall.st
Best Artificial Intelligence Stocks To Watch NowApril 25th - MarketBeat
TEM Stock Quote Price and Forecast - CNN
Tempus AI Nears Profitability as Operating Leverage Emerges - The Globe and Mail
Artificial Intelligence Stocks To Watch NowApril 24th - MarketBeat
Tempus AI Stock Faces a New Test as USC Deal Opens a 1.5 Million-Visit Door - TechStock²
Tempus AI (TEM) Stock Drops 7% Despite Landmark USC Medical Partnership - MEXC Exchange
Tempus AI (TEM) Stock Slides Even As USC Inks Major AI Health Deal - MEXC
Artificial Intelligence Clinical Trial Protocol Feasibility Tool Research Report 2026: $2.75+ Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035F - GlobeNewswire Inc.
Is It Time To Reassess Tempus AI (TEM) After Recent Share Price Volatility? - Yahoo Finance
Tempus AI partners with USC’s Keck Medicine on precision care By Investing.com - Investing.com Australia
Tempus Ai Inc (TEM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
9.61%
1.99%
자본화:
|
볼륨(24시간):